⚠ Evidence warning: Clinical trials or other evidence do not support the claim that rosemary tea relieves gas, bloating and after-meal fullness and stimulates bile flow in people. This page keeps it as a report of what people, websites or other media say.

Rosemary for Digestive and Liver Function

Digestive and Liver — scientific infographic poster

Rosemary's traditional use as a digestive remedy is older than the Renaissance herbals and is one of the few herb-and-spice applications formally codified by the German Commission E, the historical regulatory authority on European phytomedicine. Commission E approved rosemary leaf for "dyspeptic complaints" — gas, bloating, mild gastrointestinal cramping, and the sluggish digestion that follows a heavy meal. The traditional mechanism categories are carminative (relieving gas, mediated by the volatile monoterpenes 1,8-cineole and alpha-pinene relaxing intestinal smooth muscle) and cholagogue (stimulating bile flow from the gallbladder, mediated by the bitter principles and phenolic diterpenes acting on the duodenal mucosa). A separate and increasingly well-documented effect is hepatoprotection — rat models of liver injury induced by carbon tetrachloride, acetaminophen overdose, and chronic ethanol have shown reduced hepatocellular damage when carnosic acid, carnosol, or whole rosemary extract is administered before or during the toxin exposure. The mechanism is the same Nrf2 / antioxidant chemistry covered on the antioxidant page, applied to the specific oxidative-stress vulnerability of the liver. This deep-dive walks through the traditional uses, the Commission E approval, the hepatoprotective animal evidence, the COX-inhibition contribution to anti-inflammatory action in the gut, and the important cautions around essential oil dosing.


Table of Contents

  1. Traditional Carminative — the Folk Use for Gas and Bloating
  2. Cholagogue — Stimulating Bile Flow
  3. German Commission E Approval — Dyspeptic Complaints
  4. Hepatoprotection — the Rat Liver Injury Models
  5. Carbon Tetrachloride (CCl4) Hepatotoxicity
  6. Acetaminophen (Paracetamol) Hepatotoxicity
  7. Chronic Ethanol Liver Injury
  8. Cyclooxygenase-1 and Cyclooxygenase-2 Inhibition — Anti-Inflammatory Mechanism
  9. Effects on the Gut Microbiome
  10. Non-Alcoholic Fatty Liver Disease — Mechanistic Relevance
  11. How Rosemary Is Prepared for Digestion
  12. Essential Oil Cautions — the Oral Hazard
  13. Key Research Papers
  14. Connections
  15. Featured Videos

Traditional Carminative — the Folk Use for Gas and Bloating

A carminative in traditional Western herbalism is an herb that relieves intestinal gas, bloating, and the mild crampy abdominal discomfort that often accompanies heavy or rich meals. The classical carminatives include fennel, anise, caraway, dill, peppermint, ginger, and rosemary — all of them rich in volatile aromatic compounds that have direct relaxing effects on intestinal smooth muscle.

The traditional use of rosemary as a post-meal digestive aid is documented across the Mediterranean culinary tradition. Roasted meat with rosemary (still a defining preparation of Italian and Provencal cooking) is not merely a flavor pairing — the herb actively helps the digestion of the fat-rich meal it garnishes. Sprigs of fresh rosemary floated in olive oil or in red wine vinegar produce digestive tonics that have been part of European folk medicine for centuries.

The pharmacological basis of the carminative effect is well-characterized:

In people's descriptions, a cup of rosemary tea taken after a rich meal often produces noticeable belching and gas release within 10-20 minutes, accompanied by relief of post-prandial fullness. The same effect is what makes a digestif of grappa or amaro (often containing carminative herbs including rosemary) traditional in Italian cuisine.

Back to Table of Contents

Cholagogue — Stimulating Bile Flow

A cholagogue is an herb that stimulates the contraction of the gallbladder and the release of stored bile into the duodenum, accelerating the digestion of dietary fats. Bile contains bile salts (which emulsify dietary lipids and form mixed micelles with cholesterol and fat-soluble vitamins), phospholipids, cholesterol, and bilirubin. Inadequate bile flow contributes to fat maldigestion (steatorrhea, oily stools), fat-soluble vitamin malabsorption, and the bloating and discomfort associated with heavy fatty meals.

Cholagogue action by rosemary is mediated primarily by the bitter principles — the phenolic diterpenes (carnosic acid, carnosol) and the small amount of bitter components in the leaf. When these compounds contact the bitter taste receptors on the tongue and the small intestinal mucosa, they trigger a vagal reflex that stimulates gallbladder contraction and bile release. This is the same mechanism behind the European tradition of taking a bitter digestif before or after a meal — the bitter taste itself, even before absorption, activates the digestive cascade.

Cholagogue effects reported for rosemary, in rat studies and in herbal tradition:

The clinical relevance is concentrated in patients with mild functional dyspepsia, post-cholecystectomy syndrome (after gallbladder removal, when bile delivery becomes continuous-low-flow rather than meal-stimulated bolus), and the slowed digestion of aging or chronic illness. For people with documented bile flow obstruction (gallstones, biliary stricture), herbal practice generally withholds cholagogue herbs, because increasing bile flow against a partial obstruction can precipitate biliary colic. The European Medicines Agency's public summary for rosemary leaf likewise lists obstruction of the bile duct, inflammation of the gallbladder, gallstones and any liver disease as conditions in which rosemary leaf medicines are not used.

Back to Table of Contents

German Commission E Approval — Dyspeptic Complaints

The German Commission E was a multidisciplinary regulatory body established by the German Federal Institute for Drugs and Medical Devices in 1978 to evaluate the safety and efficacy of botanical medicines used in Germany. From 1978 to 1994 Commission E reviewed approximately 380 herbs and published monographs categorizing each as Approved (safety and efficacy documented), Unapproved (insufficient evidence or known safety concerns), or Neutral. The Commission E monographs remain influential in the European Medicines Agency's current herbal monograph system and in international phytomedicine practice.

Commission E approved rosemary leaf for the following internal uses:

And approved rosemary oil for the following uses (external only):

The European Medicines Agency (EMA) herbal committee assessed Rosmarini folium (rosemary leaf) together with Rosmarini aetheroleum (rosemary essential oil). Its first Community herbal monograph on rosemary leaf was adopted in 2010 and has since been superseded: a revised EU herbal monograph (Revision 1) went to public consultation from December 2022 to March 2023, and the committee's final opinion on it was published on 26 September 2024. The EMA lists rosemary leaf, sold as a herbal tea to drink and as a bath additive, for traditional use in the symptomatic relief of dyspepsia and mild spasmodic disorders of the gastrointestinal tract (indigestion and mild gut cramps), and, as a bath additive, for minor muscle and joint pain and minor peripheral circulation complaints. “Traditional use” in EMA terms means the use rests on long-standing medicinal use, not on results from clinical studies. The EMA monographs are the current regulatory standard in the EU for rosemary preparations (EMA: Rosmarini folium).

Importantly, neither Commission E nor the European Medicines Agency approves oral consumption of rosemary essential oil. The essential oil is approved only for external use (topical or aromatherapy). The dried leaf and tea preparations are the approved internal forms. See the Essential Oil Cautions section below for the safety rationale.

Back to Table of Contents

Hepatoprotection — the Rat Liver Injury Models

A separate and increasingly well-documented effect of rosemary is hepatoprotection — protection of the liver against drug- and toxin-induced injury. The evidence base is primarily in rat models because the experimental induction of severe liver injury is unethical in humans, but the mechanistic story translates plausibly through shared mammalian biochemistry.

The standard rat liver injury models in which rosemary has been tested:

  1. Carbon tetrachloride (CCl4) — the classic experimental hepatotoxin, metabolized by cytochrome P450 2E1 (CYP2E1) to trichloromethyl radicals that drive massive lipid peroxidation and centrilobular hepatocyte necrosis
  2. Acetaminophen (paracetamol) — overdose model relevant to one of the most common causes of acute liver failure in humans; toxicity mediated by the reactive metabolite NAPQI
  3. Chronic ethanol — model of alcoholic fatty liver disease and progression to steatohepatitis
  4. Thioacetamide — alternative hepatotoxin producing centrilobular necrosis
  5. Galactosamine — model resembling viral hepatitis in its periportal necrosis pattern
  6. Cadmium and other heavy metals — cumulative hepatotoxin models

In these models, rosemary extract, carnosic acid, carnosol, or rosmarinic acid given before or alongside the toxin has been reported to reduce some of the following — though not in every study or with every preparation (see the limits below the list):

The underlying mechanism in every case is the Nrf2-driven upregulation of glutathione synthesis, superoxide dismutase, catalase, and heme oxygenase-1, which collectively raise the liver's antioxidant capacity above what the toxin can overwhelm.

What these rat studies do not show. The protection depends on which part of the plant is used and on timing. In the 1987 rat study by Hoefler and colleagues, water extracts of young rosemary sprouts lowered the liver enzyme GPT (also called ALT) in the blood only when given before carbon tetrachloride poisoning; the extract of the whole plant did nothing, and neither extract helped when given after the poison. All of this work is in animals, at doses given as concentrated extracts.

Back to Table of Contents

Carbon Tetrachloride (CCl4) Hepatotoxicity

Carbon tetrachloride is the historical workhorse of experimental hepatotoxicology. It is metabolized in hepatocytes by cytochrome P450 2E1 (CYP2E1) to the highly reactive trichloromethyl free radical, which initiates massive lipid peroxidation of hepatocyte membranes, particularly the endoplasmic reticulum and mitochondrial membranes. The result is acute centrilobular hepatocyte necrosis (because cytochrome P450 2E1 is concentrated in zone 3 hepatocytes near the central vein), elevated transaminases, and at higher doses fulminant hepatic necrosis.

Rosemary CCl4 studies in rats report:

The CCl4 model is most relevant clinically as a proof-of-mechanism for general lipid-peroxidation-driven hepatocellular injury. The same mechanism is relevant to many other forms of hepatotoxicity including acetaminophen overdose, severe ischemic injury (e.g., post-liver-transplant reperfusion injury), and toxic mushroom poisoning.

Back to Table of Contents

Acetaminophen (Paracetamol) Hepatotoxicity

Acetaminophen overdose is the leading cause of acute liver failure requiring transplantation in the United States and the United Kingdom. The toxicity mechanism is well-understood:

  1. At therapeutic doses, most acetaminophen is glucuronidated or sulfated to inactive metabolites and renally excreted
  2. A small fraction is oxidized by cytochrome P450 2E1 to the reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI)
  3. NAPQI is normally rapidly conjugated and detoxified by hepatocellular glutathione
  4. At overdose, the glutathione pool is depleted, NAPQI accumulates and covalently binds hepatocyte proteins, producing oxidative stress and centrilobular necrosis
  5. The clinical antidote, N-acetylcysteine (NAC), provides cysteine for glutathione resynthesis and directly conjugates remaining NAPQI

In a 2023 rat study (Guimarães and colleagues), a rosemary glycolic extract injected into the abdominal cavity (intraperitoneally) for four days prevented liver lipid peroxidation after an acetaminophen overdose and kept blood ALT and AST at the levels of untreated rats. The proposed mechanism overlaps with the N-acetylcysteine mechanism — rosemary's Nrf2 activation upregulates the glutathione synthesis enzymes, increasing the rate at which depleted glutathione pools can be restored. This is a different mechanism than N-acetylcysteine's direct cysteine supplementation, but achieves a complementary endpoint of maintaining or restoring hepatocellular glutathione capacity.

The translational caveat: in clinical acetaminophen overdose, intravenous N-acetylcysteine remains the standard of care, started as soon as possible within the 8-hour optimal window. Rosemary extract is not a substitute for N-acetylcysteine. The conceptual interest is in dietary patterns that maintain robust baseline hepatic antioxidant defenses, potentially providing some protective margin against accidental supratherapeutic acetaminophen exposure and against the cumulative low-grade hepatotoxic stress of polypharmacy.

Back to Table of Contents

Chronic Ethanol Liver Injury

Chronic ethanol consumption produces a progression from alcoholic fatty liver (hepatic steatosis) through steatohepatitis to fibrosis and cirrhosis. The pathogenesis involves direct hepatotoxic effects of ethanol and its metabolite acetaldehyde, induction of cytochrome P450 2E1 (which generates reactive oxygen species during ethanol oxidation), depletion of hepatocellular glutathione, mitochondrial dysfunction, and chronic inflammatory activation of Kupffer cells.

Rat models of chronic ethanol-induced liver injury treated with rosemary extract or its carnosic acid have shown:

In one such study (Gao and colleagues, 2016), carnosic acid given to rats fed an ethanol liquid diet lowered blood aminotransferases, triglycerides and total cholesterol, and reduced oxidative stress, inflammation and liver-cell death.

The translational implications are limited. The protective effects in rat models do not constitute permission to consume excessive alcohol — the magnitude of human alcohol consumption that produces clinical alcoholic liver disease is far above what any dietary or supplemental antioxidant could realistically counterbalance. For patients with diagnosed alcoholic liver disease, the primary intervention is reduction or cessation of alcohol consumption; rosemary and other dietary antioxidants are at most an adjunct to it, not a replacement.

For patients with non-alcoholic fatty liver disease (NAFLD), the rosemary mechanism is more directly relevant — see the non-alcoholic fatty liver disease section below.

Back to Table of Contents

Cyclooxygenase-1 and Cyclooxygenase-2 Inhibition — Anti-Inflammatory Mechanism

A complementary anti-inflammatory mechanism contributing to rosemary's digestive and broader effects is inhibition of the cyclooxygenase enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), which convert arachidonic acid to prostaglandins and thromboxanes. Cyclooxygenase-1 is constitutively expressed and produces the "housekeeping" prostaglandins that maintain gastric mucosal integrity, platelet aggregation, and renal blood flow. Cyclooxygenase-2 is induced at sites of tissue injury and inflammation, producing the prostaglandins that drive pain, fever, and inflammation.

The non-steroidal anti-inflammatory drug class works primarily by inhibiting COX enzymes. Older nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, naproxen) inhibit both cyclooxygenase-1 and cyclooxygenase-2; the gastric ulceration side effect is attributable to the cyclooxygenase-1 inhibition that compromises gastric mucosal prostaglandin production. The selective cyclooxygenase-2 inhibitors (celecoxib) were developed to maintain anti-inflammatory efficacy while sparing gastric mucosal prostaglandins.

Rosemary extracts and isolated carnosol and rosmarinic acid have been shown to inhibit both cyclooxygenase-1 and cyclooxygenase-2 in vitro, with somewhat greater selectivity for cyclooxygenase-2 in some preparations. The clinical significance:

The potency of rosemary as a COX inhibitor is far lower than pharmaceutical nonsteroidal anti-inflammatory drugs (NSAIDs) — routine culinary use is unlikely to produce clinically significant effects equivalent to ibuprofen. High-dose extract use approaches a magnitude that could theoretically produce additive effects with low-dose aspirin or other antiplatelet drugs.

Back to Table of Contents

Effects on the Gut Microbiome

Rosemary essential oil, rosemary extracts, and isolated carnosic acid have direct antimicrobial activity against a range of bacterial and fungal species, including several human gut pathogens. This is one of the historical reasons rosemary was burned as a fumigant in medieval European sickrooms and used as a preservative for stored meat in pre-refrigeration cuisine.

Documented in vitro antimicrobial activity:

The translational significance for human gut health is moderate. The doses of rosemary consumed in cooking or in moderate tea use are unlikely to produce significant antimicrobial effects in the intact gut lumen. However, several clinical implications follow from the in vitro evidence:

Back to Table of Contents

Non-Alcoholic Fatty Liver Disease — Mechanistic Relevance

Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in the developed world, affecting an estimated 25-40% of adults. The pathogenesis involves hepatic insulin resistance, accumulation of triglycerides in hepatocytes, secondary oxidative stress and inflammation that can progress to non-alcoholic steatohepatitis (NASH), and eventually fibrosis and cirrhosis in a subset.

The mechanistic connections between rosemary's biology and non-alcoholic fatty liver disease pathophysiology:

A 2022 randomized, double-blind trial tested rosemary in people. 110 people with non-alcoholic fatty liver disease took 4 g of rosemary leaf powder or a starch placebo powder daily for 8 weeks, and everyone also received a weight-loss diet and physical-activity advice. Liver enzymes (ALT, AST, alkaline phosphatase and GGT), fasting blood sugar and insulin, insulin resistance, total and LDL cholesterol, triglycerides, weight, body mass index and waist size all fell in both groups, but the rosemary group did no better than the placebo group on any of them except one index of insulin-producing (beta-cell) function. The authors concluded that the changes in the rosemary group were not statistically different from those produced by the diet and activity programme alone. The strongest current evidence base for non-alcoholic fatty liver disease lifestyle intervention remains weight loss (5-10% body weight reduction reliably reverses steatosis in most patients) and the Mediterranean diet pattern (which includes regular rosemary use as one of many beneficial elements).

Rosemary and other Mediterranean herbs are a regular part of the Mediterranean diet pattern. As a supplement on top of weight loss, diet change and activity, rosemary leaf powder added nothing measurable over 8 weeks in the 2022 trial.

Back to Table of Contents

How Rosemary Is Prepared for Digestion

The preparations used in herbal tradition and practice for digestion:

Combination with other carminative herbs (peppermint, fennel, chamomile, ginger, lemon balm) is traditional and pharmacologically sensible — the carminative effects of different aromatic herbs often appear additive without dosage-dependent toxicity. A traditional after-dinner blend uses equal parts rosemary, peppermint, and fennel as a digestive infusion.

Back to Table of Contents

Essential Oil Cautions — the Oral Hazard

The single most important safety point about rosemary essential oil is that it is not safe for oral consumption at meaningful doses. The essential oil is far more concentrated than the dried leaf or any culinary preparation, and the volatile monoterpenes (camphor, 1,8-cineole) that produce the cognitive effects when inhaled can produce serious adverse effects when swallowed.

Documented toxicity from oral rosemary essential oil ingestion:

The fundamental safety principle: the dose makes the poison. A teaspoon of dried rosemary leaf in tea is safe and beneficial. A teaspoon of pure rosemary essential oil is a medical emergency. The 100-200x concentration difference between dried herb and essential oil is the critical safety boundary.

Approved internal use of rosemary remains the dried leaf, the leaf tea, the standardized leaf extract (not essential oil), and modest culinary use. Approved external use of the essential oil includes aromatherapy (the inhalation cognitive use covered on the cognitive page) and topical use diluted in carrier oil (the hair-loss use covered on the hair loss page).

For accidental essential oil ingestion: contact Poison Control immediately (1-800-222-1222 in the US). Do not induce vomiting (caustic essential oils may produce additional esophageal damage on emesis). Provide supportive care including airway management, hydration, and treatment of specific toxicities.

Back to Table of Contents

Key Research Papers

  1. Hoefler C et al. (1987). Comparative choleretic and hepatoprotective properties of young sprouts and total plant extracts of Rosmarinus officinalis in rats. Journal of Ethnopharmacology 19(2):133-43. — PubMed PMID: 3613606
  2. Sotelo-Félix JI et al. (2002). Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachloride-induced acute hepatotoxicity in the rat. Journal of Ethnopharmacology 81(2):145-54. — PubMed PMID: 12065145
  3. Guimarães NSS et al. (2023). Rosemary (Rosmarinus officinalis L.) Glycolic Extract Protects Liver Mitochondria from Oxidative Damage and Prevents Acetaminophen-Induced Hepatotoxicity. Antioxidants (Basel) 12(3):628. — PubMed PMID: 36978874
  4. Romo Vaquero M et al. (2013). Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Molecular Nutrition & Food Research 57(10):1834-46. — PubMed PMID: 23625681
  5. Gao L et al. (2016). Carnosic acid alleviates chronic alcoholic liver injury by regulating the SIRT1/ChREBP and SIRT1/p66shc pathways in rats. Molecular Nutrition & Food Research 60(9):1902-11. — PubMed PMID: 27125489
  6. Bozin B et al. (2007). Antimicrobial and antioxidant properties of rosemary and sage essential oils. Journal of Agricultural and Food Chemistry. — PubMed PMID: 17708648
  7. Borges RS et al. (2019). Rosmarinus officinalis essential oil: a review of its phytochemistry, anti-inflammatory activity, and mechanisms of action. Journal of Ethnopharmacology. — PubMed PMID: 30287195
  8. Akbari S et al. (2022). Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Phytotherapy Research 36(5):2186-2196. — PubMed PMID: 35318738
  9. Andrade JM et al. (2018). Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity. Future Science OA 4(4):FSO283. — PubMed PMID: 29682318

PubMed Topic Searches

  1. PubMed: Rosemary carminative / dyspepsia
  2. PubMed: Carnosic acid hepatoprotection
  3. PubMed: Rosemary cholagogue / bile
  4. PubMed: Rosemary and NAFLD
  5. PubMed: Rosemary and H. pylori

Back to Table of Contents

Connections

Back to Table of Contents